Botanical species · safety record

Tamarindus indica

The EFSA Compendium of Botanicals holds 5 constituent measurements and 1 genotoxicity assay for Tamarindus indica. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Tamarindus indica L.

5Constituent measurements

1Safety records

3Cited sources

33Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 33 licensed products naming Tamarindus indica as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Fruit
New material
Pulp
Seed(s)

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Stem / stalk	Solvent extraction	—	Phytochemical screening	Resolve DOI
Saponins	Stem / stalk	Solvent extraction	—	Phytochemical screening	Resolve DOI
Alkaloids	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Saponins	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Tannins	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

Outcome	Endpoint	Test	Tested organism	Metabolic activation	Source
Positive	DNA damage and/or repair	Mammalian erythrocyte micronucleus test	Rat (as animal)	—	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Yerima, M., Anuka, J.A., Salawu, O.A., Abdu-Aguye, I. Effect of stem-bark extract of Tamarindus indica L. On serum lipid profile, liver enzymes and blood glucose level of experimentally induced hyperglycaemic Wistar rats. Journal of Medical Sciences (Faisalabad), 2013, vol. 13, no. 8, p. 785-790. DOI
Piloto Ferrer, Janet., Vizoso Parra, Angel., Ramos Ruiz, Alberto., Garcia Lopez, Arilia., Remigio Montero, Antonia., Vega Hurtado, Yamile., Gonzalez Sanabria, Maria Lidia., Rodriguez Ferrada, Carlos., Carballo, Caridad. Medicinal Plant. Ten years of genetic toxicological evaluations in the CIDEM . Boletin latinoamericano y del caribe de plantas medicinales y aromaticas, 2009, vol. 8, no. 5, p. 428-434.
Dhasarathan, P., Premalatha, M., Syed Ali Fathima, K., Meenakshi, V. Screening the anticancerous efficacy of Tamarindus indica L. using mineral oil induced Swiss albino mice. Asian journal of microbiology, biotechnology and environmental sciences, 2010, vol. 12, no. 4, p. 937-940.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature